On April 23, 2026, Utah Medical Products Inc UTMD reported a revenue of $8.72 million for the first quarter, reflecting a decline from $9.71 million during the same period last year. This drop highlights the challenges the company faced in maintaining its sales levels in a competitive market environment.
- P/E (TTM): 20.1x, indicating how the market values the company's earnings.
- GF Scoreā¢: 81/100, suggesting a strong overall performance based on GuruFocus' proprietary metrics.
- Financial Strength: The company has a strong financial position with a debt-to-equity ratio of 0.
What's Behind the News?
The reported decline in revenue for UTMD is significant as it suggests the company is struggling to maintain its market position amidst increasing competition. The medical devices and instruments sector is known for its rapid innovation and evolving consumer demands, which can pose challenges for companies like UTMD that rely on proprietary products. As the company evaluates its strategies to enhance performance and drive growth, investors will be keen to see how management plans to address these challenges.
Utah Medical Products Inc operates within the healthcare sector, specifically in the medical devices and instruments industry. The company is involved in developing, manufacturing, and distributing medical devices primarily for hospital use. With a market cap of approximately $222.95 million and a diverse product portfolio that includes blood pressure monitoring devices, electrosurgical instruments, and neonatal care products, UTMD plays a crucial role in critical care areas of healthcare facilities.
How Is UTMD Valued?
While GF Valueā¢ data is not available for UTMD, the company's current P/E ratio stands at 20.1x. This valuation metric suggests that the stock is trading at a moderate premium compared to its earnings. Historically, the P/E ratio for similar companies in the medical devices sector can vary widely, and investors often look for a balance between growth potential and valuation. For more detailed insights, visit the UTMD stock page.
What Does UTMD's GF Scoreā¢ Tell Us?
The GF Scoreā¢ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Scoreā¢ values have been found to generate higher long-term returns (backtested 2006-2021).
| Metric | Rating |
|---|---|
| GF Scoreā¢ | 81 |
| Financial Strength | 9/10 |
| Profitability | 8/10 |
| Growth | 3/10 |
UTMD's strengths lie in its financial strength and profitability, as indicated by its high GF Scoreā¢ and strong financial metrics. However, the company's growth rank of 3/10 suggests that it may face challenges in expanding its revenue base in the near term. For more information, visit the UTMD stock page.
What Are Insiders Doing with UTMD Stock?
There has been no insider buying or selling activity reported in the last 12 months, indicating that insiders may be holding their positions in the company.
What This Means for Investors
Given the recent revenue decline and the competitive challenges faced by UTMD, investors should closely monitor the company's strategic responses and performance in upcoming quarters. The strong financial health indicated by the GF Scoreā¢ and financial metrics may provide some reassurance, but the growth outlook remains a concern.
For the complete analysis, visit the UTMD stock page. You can also use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is UTMD's GF Scoreā¢?
UTMD's GF Scoreā¢ is 81/100, indicating a strong overall performance based on various financial metrics.
How is UTMD valued?
UTMD is currently valued with a P/E ratio of 20.1x, suggesting it is trading at a moderate premium relative to its earnings.
What is UTMD's P/E ratio compared to historical?
The current P/E ratio of 20.1x is close to the higher end of the historical range for the company, indicating that it may be viewed as overvalued in the current market context.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
